Quote | AdvisorShares Psychedelics ETF (NYSE:PSIL)
Last: | $1.255 |
---|---|
Change Percent: | 0.0% |
Open: | $1.24 |
Close: | $1.255 |
High: | $1.255 |
Low: | $1.23 |
Volume: | 22,696 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
News | AdvisorShares Psychedelics ETF (NYSE:PSIL)
2023-07-16 18:00:00 ET Summary Alex Carchidi returns to update investors on the psychedelics industry. Collapse, consolidation, and why you shouldn't bet on just 1 stock. Compass Pathways' timeline for clinical trials; Atai and Cybin's recent wins. Alex Carchidi For ...
2023-07-15 18:06:24 ET Psychedelic stocks have taken it on the chin lately, with equity prices way down. Investors will have to be nimble and focus on individual stock picking, according to analyst Alex Carchidi. Speaking on Seeking Alpha's Investing Experts podcast, Carchi...
Message Board Posts | AdvisorShares Psychedelics ETF (NYSE:PSIL)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
AdvisorShares Psychedelics ETF Company Name:
PSIL Stock Symbol:
NYSE Market:
Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD A decade after it was founded as a wholly-owned ...
Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Results of a first-in-class clinical trial on ibogaine-magnesium th...
Ibogaine Therapy Shows Promising Outcomes For Veterans With Trauma Brain Injury Results of a first-in-class clinical trial on ibogaine-magnesium th...